相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
Carey K. Anders et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer
Maxime Meylan et al.
IMMUNITY (2022)
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study
Dominik A. Barth et al.
CANCER MEDICINE (2022)
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
Paul Johannet et al.
CLINICAL CANCER RESEARCH (2022)
Chemotherapy-Induced, Broadly Reactive Autoantibodies in a Colon Cancer Patient
Felix Broecker et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2022)
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
Celine M. Laumont et al.
NATURE REVIEWS CANCER (2022)
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
Can Cui et al.
CELL (2021)
IgA transcytosis and antigen recognition govern ovarian cancer immunity
Subir Biswas et al.
NATURE (2021)
Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues
Hugo de Jonge et al.
CANCERS (2021)
Beneficial autoimmunity improves cancer prognosis
Laurence Zitvogel et al.
Nature Reviews Clinical Oncology (2021)
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression
Lucile Vanhersecke et al.
NATURE CANCER (2021)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Autoantibody Landscape in Patients with Advanced Prostate Cancer
William S. Chen et al.
CLINICAL CANCER RESEARCH (2020)
The Antigen Presenting Potential of CD21low B Cells
Marlene E. Reincke et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Stefan Diem et al.
JOURNAL OF IMMUNOTHERAPY (2019)
NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline
Ryan O. Schenck et al.
BMC BIOINFORMATICS (2019)
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
Daniel P. Hollern et al.
CELL (2019)
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors
Emma C. de Moel et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
Rick L. Evans et al.
BMC CANCER (2018)
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Rituparna Das et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
Michael F. Gowen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection
Ploenchan Chetchotisakd et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis
Panos Stathopoulos et al.
JCI INSIGHT (2017)
Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer
Yukiko Tabuchi et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs
Xiaoming Liu et al.
HUMAN MUTATION (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Eps8 regulates cellular proliferation and migration of breast cancer
Cheng Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
OptiType: precision HLA typing from next-generation sequencing data
Andras Szolek et al.
BIOINFORMATICS (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Autoantibodies to tumor-associated antigens: reporters from the immune system
Eng M. Tan et al.
IMMUNOLOGICAL REVIEWS (2008)
Autoantibodies in breast cancer: their use as an aid to early diagnosis
C. Chapman et al.
ANNALS OF ONCOLOGY (2007)
Autoantibody signatures in prostate cancer
XJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The exchangeability of amino acids in proteins
LY Yampolsky et al.
GENETICS (2005)
Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients
L Zhong et al.
CANCER DETECTION AND PREVENTION (2003)
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis
EM Tan
JOURNAL OF CLINICAL INVESTIGATION (2001)